NIH grants $4.5M to Thermalin to develop insulin analogs

04/25/2012 | MedCityNews.com

The NIH awarded Thermalin Diabetes a $4.5 million grant to fund development and animal trials of next-generation insulin analogs. Unlike the natural hormone, Thermalin's analogs can be modified to tolerate heat or act faster or slower than insulin to match a patient's needs.

View Full Article in:

MedCityNews.com

Published in Brief: